Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy

NCT ID: NCT00794404

Last Updated: 2016-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

489 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-12-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the interest of enthesis sonography for the diagnosis of spondylarthritis, in patients with uncertain diagnosis consulting for clinical symptoms suggestive of spondylarthritis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spondylarthritis (SPA) are the second most frequent inflammatory rheumatic disorders and, because it starts early in life and has a chronic progressive course, the impact of this disease on health resources and patient's life quality can be important. Because the characteritic signs of SPA, like radiological evidence of sacro-iliitis, appear late in time, the lag time between the onset first signs of SPA for the patient and the confirmed diagnosis can be very long (up to 8 years). Previous studies proved that patients who are affected by SPA are showing abnormal vascularization of peripheral enthesis more frequently than patients affected by other rheumatic diseases. Ultrasonography in B mode combined with power Doppler (PDUS) is a non invasive and highly sensitive toll which can detect enthesitis and abnormal vsacularization even for the patients who are not showing yet the evidence of SPA's symptomatology. Using PDUS as a early diagnosis tool could lead to the improvement of diagnostic procedures and therapeutic management of SpA and reduce the cost of diagnosis for patient and health insurances.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spondylarthropathy Ankylosing Spondyloarthitis Spondyloarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients \< 50 years old, consulting for spinal inflammatory symptoms \> 3 months duration
* patients consulting for arthritis or tenderness joints \> 3 months duration
* patients \< 50 years old consulting for enthesitis or dactylitis \> 3 months duration
* patients with uveitis and HLA-B27 positivity
* relatives of SpA patients consulting for symptoms suggestive of SpA

Exclusion Criteria

* patient with confirmed diagnosis of rheumatic disease (included SpA)
* patient protected by law (patient \<18 years old, pregnant woman)
* patient who can't atempt the RMI
* patient who will have difficulties to complete the two years of follow-up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Français d'Etude Génétique des Spondylarthropathies

OTHER

Sponsor Role collaborator

French Society of Rheumatology

OTHER

Sponsor Role collaborator

Dr Maria-Atonietta D'AGOSTINO

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Maria-Atonietta D'AGOSTINO

PU-PH

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

D'AGOSTINO Maria-Antonietta, MCUPH

Role: PRINCIPAL_INVESTIGATOR

Ambroise Paré Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ambroise Paré Hospital

Boulogne-Billancourt, , France

Site Status

Cavale Blanche Hospital

Brest, , France

Site Status

Cote de Nacre Hospital

Caen, , France

Site Status

South Hospital of Grenoble

Échirolles, , France

Site Status

Conception Hospital

Marseille, , France

Site Status

Nancy Brabois Hospital

Vandœuvre-lès-Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Devauchelle-Pensec V, D'Agostino MA, Marion J, Lapierre M, Jousse-Joulin S, Colin D, Chary-Valckenaere I, Marcelli C, Loeuille D, Aegerter P, Guis S, Gaudin P, Breban M, Saraux A; Study Group of Spondylarthritis. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum. 2012 May;64(5):1412-9. doi: 10.1002/art.33466.

Reference Type DERIVED
PMID: 22081446 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GESPA

Identifier Type: -

Identifier Source: org_study_id